BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 31754749)

  • 1. Clinical and genetic correlates of islet-autoimmune signatures in juvenile-onset type 1 diabetes.
    Claessens LA; Wesselius J; van Lummel M; Laban S; Mulder F; Mul D; Nikolic T; Aanstoot HJ; Koeleman BPC; Roep BO
    Diabetologia; 2020 Feb; 63(2):351-361. PubMed ID: 31754749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a Selective Islet Peptidome Presented by the Highest-Risk HLA-DQ8trans Molecule.
    van Lummel M; van Veelen PA; de Ru AH; Pool J; Nikolic T; Laban S; Joosten A; Drijfhout JW; Gómez-Touriño I; Arif S; Aanstoot HJ; Peakman M; Roep BO
    Diabetes; 2016 Mar; 65(3):732-41. PubMed ID: 26718497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do non-HLA genes influence development of persistent islet autoimmunity and type 1 diabetes in children with high-risk HLA-DR,DQ genotypes?
    Steck AK; Zhang W; Bugawan TL; Barriga KJ; Blair A; Erlich HA; Eisenbarth GS; Norris JM; Rewers MJ
    Diabetes; 2009 Apr; 58(4):1028-33. PubMed ID: 19188433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro- and anti-inflammatory cytokine production by autoimmune T cells against preproinsulin in HLA-DRB1*04, DQ8 Type 1 diabetes.
    Durinovic-Belló I; Schlosser M; Riedl M; Maisel N; Rosinger S; Kalbacher H; Deeg M; Ziegler M; Elliott J; Roep BO; Karges W; Boehm BO
    Diabetologia; 2004 Mar; 47(3):439-450. PubMed ID: 14745491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quarter of patients with type 1 diabetes have co-existing non-islet autoimmunity: the findings of a UK population-based family study.
    Kozhakhmetova A; Wyatt RC; Caygill C; Williams C; Long AE; Chandler K; Aitken RJ; Wenzlau JM; Davidson HW; Gillespie KM; Williams AJK
    Clin Exp Immunol; 2018 Jun; 192(3):251-258. PubMed ID: 29431870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of Type 1 diabetes and associated autoimmunity.
    Walter M; Albert E; Conrad M; Keller E; Hummel M; Ferber K; Barratt BJ; Todd JA; Ziegler AG; Bonifacio E
    Diabetologia; 2003 May; 46(5):712-20. PubMed ID: 12750767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic Cells Guide Islet Autoimmunity through a Restricted and Uniquely Processed Peptidome Presented by High-Risk HLA-DR.
    van Lummel M; van Veelen PA; de Ru AH; Janssen GM; Pool J; Laban S; Joosten AM; Nikolic T; Drijfhout JW; Mearin ML; Aanstoot HJ; Peakman M; Roep BO
    J Immunol; 2016 Apr; 196(8):3253-63. PubMed ID: 26944932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group.
    Horton V; Stratton I; Bottazzo GF; Shattock M; Mackay I; Zimmet P; Manley S; Holman R; Turner R
    Diabetologia; 1999 May; 42(5):608-16. PubMed ID: 10333055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated Progression to Type 1 Diabetes in the Presence of
    Balke EM; Balti EV; Van der Auwera B; Weets I; Costa O; Demeester S; Abrams P; Casteels K; Coeckelberghs M; Tenoutasse S; Keymeulen B; Pipeleers DG; Gorus FK;
    Diabetes Care; 2018 May; 41(5):1076-1083. PubMed ID: 29545461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class II HLA Genotype Association With First-Phase Insulin Response Is Explained by Islet Autoantibodies.
    Koskinen MK; Lempainen J; Löyttyniemi E; Helminen O; Hekkala A; Härkönen T; Kiviniemi M; Simell O; Knip M; Ilonen J; Toppari J; Veijola R
    J Clin Endocrinol Metab; 2018 Aug; 103(8):2870-2878. PubMed ID: 29300921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late-onset islet autoimmunity in childhood: the Diabetes Autoimmunity Study in the Young (DAISY).
    Frohnert BI; Ide L; Dong F; Barón AE; Steck AK; Norris JM; Rewers MJ
    Diabetologia; 2017 Jun; 60(6):998-1006. PubMed ID: 28314946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic prediction of autoimmunity: initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4-DQ8 relatives of patients with type 1A diabetes.
    Aly TA; Ide A; Humphrey K; Barker JM; Steck A; Erlich HA; Yu L; Miao D; Redondo MJ; McFann K; Roberts CM; Babu SR; Norris JM; Eisenbarth GS; Rewers MJ
    J Autoimmun; 2005; 25 Suppl():40-5. PubMed ID: 16242305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
    Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
    Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterozygosity for MICA5.0/MICA5.1 and HLA-DR3-DQ2/DR4-DQ8 are independent genetic risk factors for latent autoimmune diabetes in adults.
    Törn C; Gupta M; Nikitina Zake L; Sanjeevi CB; Landin-Olsson M
    Hum Immunol; 2003 Sep; 64(9):902-9. PubMed ID: 12941547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic susceptibility to type 1 diabetes in childhood - estimation of HLA class II associated disease risk and class II effect in various phases of islet autoimmunity.
    Ilonen J; Kiviniemi M; Lempainen J; Simell O; Toppari J; Veijola R; Knip M;
    Pediatr Diabetes; 2016 Jul; 17 Suppl 22():8-16. PubMed ID: 27411431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early onset of diabetes in the proband is the major determinant of risk in HLA DR3-DQ2/DR4-DQ8 siblings.
    Gillespie KM; Aitken RJ; Wilson I; Williams AJ; Bingley PJ
    Diabetes; 2014 Mar; 63(3):1041-7. PubMed ID: 24203724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extreme genetic risk for type 1A diabetes.
    Aly TA; Ide A; Jahromi MM; Barker JM; Fernando MS; Babu SR; Yu L; Miao D; Erlich HA; Fain PR; Barriga KJ; Norris JM; Rewers MJ; Eisenbarth GS
    Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14074-9. PubMed ID: 16966600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flexible peptide recognition by HLA-DR triggers specific autoimmune T-cell responses in autoimmune thyroiditis and diabetes.
    Li CW; Osman R; Menconi F; Concepcion ES; Tomer Y
    J Autoimmun; 2017 Jan; 76():1-9. PubMed ID: 27670087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving prediction of type 1 diabetes by testing non-HLA genetic variants in addition to HLA markers.
    Steck AK; Dong F; Wong R; Fouts A; Liu E; Romanos J; Wijmenga C; Norris JM; Rewers MJ
    Pediatr Diabetes; 2014 Aug; 15(5):355-62. PubMed ID: 25075402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-risk genotypes HLA-DR3-DQ2/DR3-DQ2 and DR3-DQ2/DR4-DQ8 in co-occurrence of type 1 diabetes and celiac disease.
    Smigoc Schweiger D; Mendez A; Kunilo Jamnik S; Bratanic N; Bratina N; Battelino T; Brecelj J; Vidan-Jeras B
    Autoimmunity; 2016 Jun; 49(4):240-7. PubMed ID: 27138053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.